New insights into the pathogenesis of asthma

Journal of Clinical Investigation

Volumn 111, Issue 3, 2003, Pages 291-297

  Elias, Jack A ^a   Lee, Chun Geun ^a   Zheng, Tao ^a   Ma, Bing ^a   Homer, Robert J ^a   Zhu, Zhou ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; BCG VACCINE; BRONCHODILATING AGENT; CD4 ANTIGEN; CORTICOSTEROID; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOLOGIC AGENT; INTERLEUKIN 12; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; METHACHOLINE; OLIGODEOXYNUCLEOTIDE; SLOW REACTING SUBSTANCE; STAT6 PROTEIN; THEOPHYLLINE DERIVATIVE;

AIRWAY OBSTRUCTION; ASTHMA; AUTONOMIC DYSFUNCTION; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; DRUG TARGETING; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; LUNG FUNCTION; MACROPHAGE ACTIVATION; MAST CELL DEGRANULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SIDE EFFECT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0037314229     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17748     Document Type: Review

References (19)

1. Neurath, M.F., Finotto, S., and Glimcher, L.H. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567-573.
2. Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C., and DeKruyff, R.H. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
3. Finotto, S., et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295:336-338.
4. Ray, A., and Cohn, L. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 104:1001-1006.
5. Tournoy, K.G., Kips, J.C., and Pauwels, R.A. 2002. Is Th1 the solution for Th2 in asthma? Clin. Exp. Allergy. 32:17-29.
6. Zheng, T., et al. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin. Invest. 106:1081-1093.
7. Zhu, Z., Ma, B., Homer, R.J., Zheng, T., and Elias, J.A. 2001. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J. Biol. Chem. 276:25222-25299.
8. Zhu, Z., et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production. J. Clin. Invest. 103:779-788.
9. Temann, U.A., Ray, P., and Flavell, R.A. 2002. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin. Invest. 109:29-39. doi: 10.1172/JCI200213696.
10. Lanone, S., et al. 2002. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110:463-474. doi: 10.1172/JCI200214136.
11. Zhu, Z., et al. 2002. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 168:2953-2962.
12. 1. J. Exp. Med. 194:809-821.
13. 1995. Global initiative for asthma: global strategy for asthma management and prevention. NHLBI/WHO workshop report. NIH, National Heart, Lung and Blood Institute. Bethesda, Maryland, USA. Publication number 95-3659.
14. Henderson, W.R., Jr., et al. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165:108-116.
15. Ito, K., et al. 2002. Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. 166:392-396.
16. Ito, K., et al. 2002. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA. 99:8921-8926.
17. Milgrom, H., et al. 1999. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N. Engl. J. Med. 341:1966-1973.
18. Donaldson, D.D., Elias, J.A., and Wills-Karp, M. 2001. IL-13 antagonism. In Progress in respiratory research: new drugs in asthma, allergy and COPD. Volume 31. T. Hansel and P. Barnes, editors. Karger Press. Basel, Switzerland. 260-263.
19. Sampath, D., Castro, M., Look, D.C., and Holtzman, M.J. 1999. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J. Clin. Invest. 103:1353-1361.